KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $42.8 billion.

  • Bristol Myers Squibb's Non-Current Debt fell 998.47% to $42.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $42.8 billion, marking a year-over-year decrease of 998.47%. This contributed to the annual value of $42.8 billion for FY2025, which is 998.47% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Non-Current Debt of $42.8 billion as of Q4 2025, which was down 998.47% from $44.5 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Non-Current Debt high stood at $49.5 billion for Q1 2024, and its period low was $32.1 billion during Q3 2023.
  • Moreover, its 5-year median value for Non-Current Debt was $41.1 billion (2021), whereas its average is $41.2 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first plummeted by 1806.31% in 2021, then soared by 5145.78% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Non-Current Debt stood at $39.6 billion in 2021, then fell by 11.49% to $35.1 billion in 2022, then rose by 4.56% to $36.7 billion in 2023, then grew by 29.87% to $47.6 billion in 2024, then fell by 9.98% to $42.8 billion in 2025.
  • Its Non-Current Debt stands at $42.8 billion for Q4 2025, versus $44.5 billion for Q3 2025 and $44.5 billion for Q2 2025.